Adaptive Galerkin approximation algorithms for Kolmogorov equations in infinite dimensions by Schwab, C, Süli, E

Adaptive Galerkin approximation algorithms for partial differential equations in infinite dimensions by Schwab, C, Suli, E

Discontinuous hp-Finite Element Methods for Advection-Diffusion Problems by Houston, P, Schwab, C, Suli, E

hp-DGFEM for Partial Differential Equations with Nonnegative Characteristic Form by Suli, E, Schwab, C, Houston, P

Sparse finite element approximation of high-dimensional transport-dominated diffusion problems by Schwab, C, Sueli, E, Todor, R

Sparse finite element approximation of high-dimensional transport-dominated diffusion problems by Schwab, C, Suli, E, Todor, R

Hp-finite element methods for hyperbolic problems by Suli, E, Houston, P, Schwab, C

Stabilized hp-Finite Element Methods for First-Order Hyperbolic Problems by Houston, P, Schwab, C, Suli, E

Stabilized hp-finite element methods for first-order hyperbolic problems by Houston, P, Schwab, C, Suli, E

Discontinuous hp-finite element methods for advection-diffusion-reaction problems by Houston, P, Schwab, C, Suli, E

Existence of Global Weak Solutions for Some Polymeric Flow Models by Barrett, J, Schwab, C, Suli, E

hp-Finite Element Methods for Hyperbolic Problems by Suli, E, Houston, P, Schwab, C

Existence of global weak solutions for some polymeric flow models by Barrett, J, Schwab, C, Suli, E

hp-DGFEM for partial differential equations with nonnegative characteristic form by Suli, E, Schwab, C, Houston, P

Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics by Moorman, A, Enshaie, A, Chilton, L, Schwab, C, Tembo, T, Richards, S, Kinsey, S, Vora, A, Mitchell, C, Harrison, C

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. by Moorman, A, Ensor, H, Richards, S, Chilton, L, Schwab, C, Kinsey, SE, Vora, A, Mitchell, C, Harrison, C

Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplificatio... by Moorman, A, Robinson, H, Schwab, C, Richards, S, Hancock, J, Mitchell, C, Goulden, N, Vora, A, Harrison, C

Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor. by Enshaei, A, Schwab, C, Konn, Z, Mitchell, C, Kinsey, SE, Wade, R, Vora, A, Harrison, C, Moorman, A

Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor by Enshaei, A, Schwab, C, Konn, Z, Mitchell, C, Kinsey, SE, Wade, R, Vora, A, Harrison, C, Moorman, A

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial. by Ensor, H, Schwab, C, Russell, L, Richards, S, Morrison, H, Masic, D, Jones, L, Kinsey, SE, Vora, A, Mitchell, C, Harrison, C, Moorman, A